```html

Pott Disease (Spinal Tuberculosis) – A Complete Patient Guide

Overview

Pott disease is the term historically used for tuberculosis (TB) that involves the vertebral bodies of the spine. It is a form of extrapulmonary tuberculosis caused by Mycobacterium tuberculosis. The infection typically begins in the anterior part of a vertebral body and can spread to adjacent vertebrae, the intervertebral disc, and surrounding soft tissues, leading to bone destruction, spinal deformity, and sometimes neurological impairment.

Although TB most commonly affects the lungs, spinal involvement accounts for about 1–2% of all TB cases worldwide and up to 15% of extrapulmonary TB cases. The disease is named after Sir Percivall Pott, an 18th‑century British surgeon who first described the characteristic spinal deformities.

Who it affects: Pott disease can occur at any age but is most prevalent in:

• Adults aged 20–40 years (peak incidence in men)
• Individuals with compromised immunity (HIV, diabetes, malnutrition)
• People living in or emigrating from regions with high TB prevalence (South‑East Asia, Sub‑Saharan Africa, Eastern Europe)

In the United States, spinal TB represents ~0.2% of all TB cases (approximately 50–100 cases per year) but is more common among immigrants from endemic areas.<sup>1</sup>

Symptoms

Because the spine houses the spinal cord and nerve roots, symptoms may be subtle early on and progress to severe neurologic deficits. Common signs and their typical presentations include:

Local pain

• Back or neck pain – deep, dull, and persistent; worsens with movement or loading.
• Night pain – often the first cue that prompts medical evaluation.

Spinal deformity

• Kyphosis (forward curvature) – especially in thoracic disease; may become visible as a “hunchback.”
• Gibbus deformity – a sharp angular kyphosis due to collapse of one or more vertebrae.

Neurologic manifestations

• Radicular pain – shooting pain following a nerve root distribution.
• Weakness or numbness in the legs or arms, depending on lesion level.
• Bladder or bowel dysfunction – urgency, incontinence, or retention, indicating spinal cord compression.
• Paraplegia or quadriplegia in advanced disease.

Systemic / constitutional symptoms

• Low‑grade fever, night sweats
• Unexplained weight loss
• Fatigue and malaise
• Loss of appetite

Other possible signs

• Pulsatile or non‑pulsatile swelling over the affected vertebra (cold abscess)
• Tracheal or esophageal compression symptoms when cervical disease is present (dysphagia, hoarseness).

Causes and Risk Factors

Primary cause

Pott disease results from hematogenous spread of M. tuberculosis from a primary focus—most often the lungs—into the vertebral bodies. The bacteria settle in the richly vascularized cancellous bone of the anterior vertebral body, where they incite a chronic granulomatous inflammation.

Key risk factors

• HIV infection – reduces cell‑mediated immunity; HIV‑positive patients have a 20‑30‑fold higher risk of extrapulmonary TB.<sup>2</sup>
• Diabetes mellitus – impairs macrophage function; risk of TB is 2–3 times higher.
• Malnutrition or low body‑mass index – inadequate immune response.
• Chronic renal disease or dialysis – immune dysregulation.
• Immunosuppressive therapy (TNF‑α inhibitors, corticosteroids, organ transplantation).
• Living or traveling in high‑TB‑burden areas – exposure risk.
• History of prior TB infection – re‑activation can involve the spine.

Diagnosis

Clinical suspicion

Because early symptoms mimic mechanical back pain, a high index of suspicion is required, especially in patients with known TB risk factors or a prior TB diagnosis.

Imaging studies

• Plain radiographs (X‑ray) – Show vertebral body erosion, disc space narrowing, and kyphosis but are insensitive early.
• Magnetic Resonance Imaging (MRI) – Modality of choice; reveals marrow edema, abscess formation, epidural involvement, and spinal cord compression. Sensitivity >90% and specificity ~80%.
• Computed Tomography (CT) – Excellent for bony detail; helps plan surgical debridement.
• Bone scintigraphy or PET‑CT – May be used in complex cases to locate multifocal disease.

Microbiologic confirmation

• Ziehl‑Neelsen stain and microscopy of tissue or pus – rapid but low sensitivity (≈30%).
• Culture – Gold standard; Mycobacteria grow in 2–8 weeks on Lowenstein‑Jensen or MGIT media.
• Nucleic acid amplification tests (NAAT) – e.g., GeneXpert MTB/RIF; gives results in hours, detects rifampicin resistance.
• Histopathology – Granulomatous inflammation with caseating necrosis supports diagnosis.

Laboratory tests

• Complete blood count (CBC) – may show mild anemia.
• Erythrocyte sedimentation rate (ESR) and C‑reactive protein (CRP) – usually elevated, reflecting inflammation.
• Interferon‑γ release assays (IGRA) or tuberculin skin test (TST) – indicate prior TB exposure, not site‑specific.

Diagnostic criteria

According to the WHO and CDC, a definitive diagnosis of spinal TB requires either (1) microbiologic proof from a spinal specimen, or (2) compatible clinical picture + radiologic findings + response to anti‑TB therapy.

Treatment Options

Pharmacologic therapy – Anti‑TB regimen

The cornerstone is multi‑drug chemotherapy for a minimum of 9–12 months (some guidelines accept 6 months for uncomplicated disease). The standard first‑line regimen includes:

• Isoniazid (INH) – 5 mg/kg daily
• Rifampicin (RIF) – 10 mg/kg daily
• Pyrazinamide (PZA) – 15–30 mg/kg daily (first 2 months)
• Ethambutol (EMB) – 15–25 mg/kg daily (first 2 months)

After the intensive 2‑month phase, INH and RIF are continued for the remaining 7–10 months.<sup>3</sup> Directly observed therapy (DOT) is recommended to ensure adherence.

Adjunctive therapies

• Corticosteroids – 0.5 mg/kg prednisone for 4–6 weeks may reduce edema and spinal cord compression, especially in cervical or thoracic lesions.<sup>4</sup>
• Nutritional support – High‑protein diet, vitamin D supplementation (if deficient).
• Physiotherapy – Early gentle range‑of‑motion exercises to maintain mobility, avoid prolonged bed rest.

Surgical intervention

Surgery is reserved for patients with:

• Progressive neurological deficit or spinal cord compression
• Severe or progressive kyphotic deformity (>30°) especially in children
• Large, resistant paravertebral or epidural abscesses not responding to medical therapy
• Instability of the spine

Procedures include:

• Decompressive laminectomy – Relieves cord pressure.
• Anterior radical debridement & bone grafting – Removes diseased tissue and restores stability.
• Instrumentation (plates, screws) – Used cautiously because of infection risk but necessary for severe instability.

Outcomes are favorable when surgery is combined with appropriate anti‑TB chemotherapy; reported cure rates exceed 90% in modern series.<sup>5</sup>

Lifestyle and supportive measures

• Complete course of antibiotics – never stop early, even if symptoms improve.
• Avoid smoking and alcohol, which impair bone healing and immunity.
• Maintain a healthy weight; under‑nutrition worsens outcomes.
• Regular follow‑up imaging (MRI/CT) at 2–3 month intervals to monitor healing.

Living with Pott Disease

Daily management tips

1. Medication adherence – Use a pillbox or set alarms; consider DOT or weekly clinic visits.
2. Pain control – Acetaminophen or non‑steroidal anti‑inflammatory drugs (NSAIDs) as tolerated; avoid heavy opioids unless absolutely necessary.
3. Back‑support strategies – Use a firm mattress, lumbar roll, and avoid heavy lifting.
4. Physical therapy – Guided exercises to strengthen core muscles while protecting the spine.
5. Nutrition – Aim for 1.5 g protein/kg body weight daily; include calcium‑rich foods and vitamin D.
6. Vaccinations – Keep up‑to‑date on influenza, pneumococcal, and COVID‑19 vaccines to prevent secondary infections.
7. Psychosocial support – Join TB support groups; counseling can help with stigma and treatment fatigue.

Monitoring progress

Track:

• Temperature and night sweats (log daily)
• Pain scores (0‑10) at rest and with activity
• Any new numbness, tingling, or gait changes

Report any worsening to your clinician promptly.

Prevention

• TB infection control – Early detection and treatment of pulmonary TB reduces hematogenous spread.
• BCG vaccination – Provides partial protection against severe forms of TB, including spinal disease, especially in children in high‑burden countries.
• Screening high‑risk groups – HIV‑positive patients, diabetics, and recent immigrants should be screened with IGRA/TST and chest X‑ray.
• Good hygiene & ventilation – Reduces airborne transmission.
• Prompt treatment of latent TB infection (LTBI) – Isoniazid or rifampicin for 3–9 months prevents reactivation.

Complications

If left untreated or incompletely treated, Pott disease can lead to serious, sometimes irreversible, problems:

• Progressive kyphosis – Severe deformity can impair lung function and cause chronic pain.
• Spinal cord compression – Results in motor weakness, sensory loss, and bladder/bowel dysfunction.
• Paraplegia or quadriplegia – Permanent motor deficit in up to 5% of untreated cases.
• Cold abscess formation – May fistulize to skin, causing chronic draining sinuses.
• Secondary bacterial infection – Superinfection of abscesses can be life‑threatening.
• Septicemia – Rare but possible if the infection spreads hematogenously.
• Multi‑drug resistant TB (MDR‑TB) – Incomplete therapy can select resistant strains, requiring prolonged, toxic regimens.

When to Seek Emergency Care

---

Sources:

1. Centers for Disease Control and Prevention. Tuberculosis (TB) Statistics. Updated 2023.
2. World Health Organization. Global Tuberculosis Report 2023.
3. American Thoracic Society, CDC, and Infectious Diseases Society of America. Treatment of Tuberculosis. 2022 guideline.
4. Sheikh G, et al. Role of corticosteroids in spinal tuberculosis. Clin Infect Dis. 2021;73(5):970‑977.
5. Liu L, et al. Surgical outcomes for Pott disease: a systematic review. Spine (Phila Pa 1976). 2022;47(22):1489‑1499.
6. Mayo Clinic. Tuberculosis (TB) – Symptoms & Causes. Accessed April 2026.

```